- Home
- PULM vs HTCR Comparison
PULM vs HTCR Comparison
Compare PULM & HTCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PULM
- HTCR
- Stock Information
- Founded
- PULM 2003
- HTCR 2009
- Country
- PULM United States
- HTCR Japan
- Employees
- PULM N/A
- HTCR N/A
- Industry
- PULM Biotechnology: Pharmaceutical Preparations
- HTCR EDP Services
- Sector
- PULM Health Care
- HTCR Technology
- Exchange
- PULM Nasdaq
- HTCR Nasdaq
- Market Cap
- PULM 18.3M
- HTCR 21.2M
- IPO Year
- PULM N/A
- HTCR 2022
- Fundamental
- Price
- PULM $4.87
- HTCR $0.77
- Analyst Decision
- PULM
- HTCR
- Analyst Count
- PULM 0
- HTCR 0
- Target Price
- PULM N/A
- HTCR N/A
- AVG Volume (30 Days)
- PULM 17.6K
- HTCR 2.6M
- Earning Date
- PULM 10-16-2025
- HTCR 11-13-2025
- Dividend Yield
- PULM N/A
- HTCR N/A
- EPS Growth
- PULM N/A
- HTCR N/A
- EPS
- PULM N/A
- HTCR N/A
- Revenue
- PULM $3,000.00
- HTCR $29,625,381.00
- Revenue This Year
- PULM N/A
- HTCR N/A
- Revenue Next Year
- PULM $134.88
- HTCR $3.52
- P/E Ratio
- PULM N/A
- HTCR N/A
- Revenue Growth
- PULM N/A
- HTCR 72.95
- 52 Week Low
- PULM $2.00
- HTCR $0.39
- 52 Week High
- PULM $10.40
- HTCR $3.38
- Technical
- Relative Strength Index (RSI)
- PULM 50.82
- HTCR 45.96
- Support Level
- PULM $4.55
- HTCR $0.68
- Resistance Level
- PULM $4.95
- HTCR $0.82
- Average True Range (ATR)
- PULM 0.21
- HTCR 0.07
- MACD
- PULM 0.02
- HTCR -0.00
- Stochastic Oscillator
- PULM 46.72
- HTCR 38.64
About PULM Pulmatrix Inc.
Pulmatrix Inc is a biopharmaceutical company that has focused on the development of novel inhaled therapeutic products intended to prevent and treat migraine and respiratory diseases with important unmet medical needs using its patented dry powder delivery technology, iSPERSE. Its pipeline of clinical assets includes PUR3100 for the treatment of acute migraine, PUR1800 for the treatment of acute exacerbations of chronic obstructive pulmonary disease (AECOPD), and PUR1900 for the treatment of ABPA in patients with asthma and in patients with cystic fibrosis (CF).
About HTCR Heartcore Enterprises Inc.
HeartCore Enterprises Inc is a software development company. The company provides software through two business units. The first business unit includes a customer experience management business. The customer experience management platform includes marketing, sales, service, and content management systems, as well as other tools and integrations that enable companies to attract and engage customers throughout the customer experience. It also provides education, services and support to help customers be successful with the CXM Platform. The second business unit, DX division, is a digital transformation business that provides customers with robotics process automation, process mining, and task mining to accelerate the digital transformation of enterprises.